Skip to content

Incretin Secretion in Women With Polycystic Ovary Syndrome (PCOS)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00647023
Enrollment
66
Registered
2008-03-31
Start date
2004-02-29
Completion date
2006-05-31
Last updated
2008-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome

Brief summary

The incretin hormones are secreted from the gastrointestinal tract in response to nutrient ingestion, and are responsible for 70 % of insulin secretion in response to glucose. The incretin response is attenuated in subjects with type 2 diabetes and other conditions associated with insulin resistance. Polycystic ovary syndrome (PCOS) is characterised by irregular periods and increased androgen levels. It is the most common endocrine disorder amongst young women at fertile age, and the most common cause of female infertility. Insulin resistance plays an important role in the development of the disease, and women with PCOS are at increased risk of developing tyoe 2 diabetes. the incretin hormones have not previously been investigated in women with PCOS, and the purpose of the present study was to investigate the secretion of the two most important incretin hormones Glucose-like peptide-1 (GLP-1) and Glucose dependent insulinotropic peptide (GIP) during a three hour oral glucose tolerance test.

Interventions

DRUGmetformin

1000 mg metformin x 2 daily during 8 months

Sponsors

University of Copenhagen
CollaboratorOTHER
Hvidovre University Hospital
Lead SponsorOTHER

Study design

Primary purpose
BASIC_SCIENCE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 38 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects who fulfill the Rotterdam criteria for PCOS. Age 18-38

Exclusion criteria

* Other endocrine diseases or diseases known to influence glucose/insulin/fat metabolism * Oral contraceptive administration within three months of study start

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026